REVOLAX is an advanced dermal filler, formulated with high-purity hyaluronic acid. As a medical grade III dermal filler, REVOLAX boasts a market-leading safety profile, backed by clinical research and pioneering cross-linking technology.
REVOLAX acts as your IRL filter, enhancing facial features through volumisation. With three dermal filler formulas to choose from, REVOLAX offers a versatile range of treatment options, whether you’re looking to plump, sculpt or smooth.
Quality, safety and results are our priorities. REVOLAX has a gel like consistency with a monophasic structure, consisting of a regular and dense lattice. This enables stability, consistency and a smooth injection protocol.
This unique configuration promotes a strong support system within the skin structure, for long-lasting, naturally-harmonised volume. REVOLAX’s structure is incomparable to other HA fillers in the market, offering advanced durability whilst maintaining visco-elasticity and elasticity. REVOLAX is designed to create natural-looking end results from the initial treatment all the way up until the product is fully absorbed into the skin.
As hyaluronic acid occurs naturally in the body, HA filler is able to synchronise with skin tissue, offering natural-looking, harmonised results.
High visco-elasticity is one of REVOLAX’s stand-out properties. The malleable consistency creates immediate and long-lasting volume, allowing the product to break down evenly to produce a natural finish.
Stringent quality checks remove traces of the cross-linking agent BDDE from the finished product, through a rigorous dialysis process.
The REVOLAX dermal filler range has a unique cross-linking structure which maintains a low percentage of product migration, allowing the product to remain close to the injection site.
The hero ingredient. REVOLAX is made from 100% non-animal based, high purity hyaluronic acid (HA). HA is one of the most powerful hydrating ingredients and is naturally produced by the body. Boasting impressive moisturising properties, hyaluronic acid is a humectant, meaning that its molecules can attract up to 1,000 times their own weight in water. This enables REVOLAX to provide effective hydration.
Hyaluronic acid molecules have immunological tolerance, and therefore assist in the regeneration of collagen – the perfect solution for volumising and moisturising the skin.
To be considered as a cosmetic treatment, HA must be chemically modified to prevent decomposition. This process transforms HA from a liquid into a gel by crosslinking the polymer chains to one another, allowing the molecules to fill wrinkles and maintain their shape. As REVOLAX is highly cross-linked, the skin takes longer to break down the filler, meaning that REVOLAX results are long-lasting in comparison to other dermal fillers.
|
|
Composition | Recomended Indications | Injection Depth | Volume | Complex Viscosity | Needle Size | Duration | Storage | Shelf Life | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RevolaxTM Fine With Lidocaine |
HA 24mg/ml Lidocaine 0.3% |
Superficial lines; |
Superficial Dermis |
1.1ml |
80 |
30G |
9-12 Months |
2-25 °C |
24 Months | ||||||||||
|
RevolaxTM Deep |
HA 24mg/ml Lidocaine 0.3% |
Lips |
Mid/Deep Dermis, Subcutaneous |
1.1ml |
160 |
27G |
12-18 Months |
2-25 °C |
24 Months | ||||||||||
|
RevolaxTM SubQ |
HA 24mg/ml Lidocaine 0.3% |
Severely Deep Lines |
Deep Subcutaneous |
1.1ml |
280 |
25G |
12-18 Months |
2-25 °C |
24 Months |
Hyaluronic Acid: derived from streptococcus zooepidemicus
Crosslinked HA: 100%
Crosslinked Agent: BDDE
BDDE Residue in final product: Not Detected
Those who are pregnant or breastfeeding
Patients who are known to demonstrate hypersensitivity to Hyaluronic Acid
Patients who tend to develop hypertrophic scarring
Immediately before or post laser therapy, chemical peeling, or dermabrasion
Areas presenting cutaneous inflammation or signs of infection
Fear of missing out?
Keep in the know with the latest news, aesthetics info, and REVOLAX results.
